BriaCell Therapeutics Corp - Ordinary Shares - New

NASDAQ:BCTX  
8.00
-0.13 (-1.60%)
7:55:23 PM EDT: $7.98 -0.02 (-0.25%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

BriaCell Therapeutics Corp - Ordinary Shares - New Stock, NASDAQ:BCTX

Bellevue Centre, 235 -15th Street, West Vancouver, British Columbia V7T 2X1
Canada
Phone: +1.604.921.1810
Number of Employees: 18
http://www.briacell.com

Description

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMTâ„¢ targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer. The company was founded by Charles L. Wiseman and Isaac Benjamin Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.